NCT04693377
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +66 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Metastatic Thyroid Gland Carcinoma
Explore clinical trials studying Metastatic Thyroid Gland Carcinoma. Study availability and eligibility vary by location and protocol.
7 public trials
1 recruiting study
Metastatic Thyroid Gland Carcinoma trial results
NCT02393690
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Hoag Memorial Hospital Newport Beach, California, United States
- University of Colorado Hospital Aurora, Colorado, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
Active, Not Recruiting
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
NCT01947023
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +6 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
NCT02152995
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +23 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
NCT04061980
- Conditions
- BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Endocrine Gland Neoplasms, +11 more
- Locations
-
- Providence Portland Medical Center Portland, Oregon, United States
Active, Not Recruiting
Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer
NCT04171622
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States